An Adaptive Randomization method based on a Patient's Characteristics used in phase 2 and phase 3 clinical trials that focuses on personalizing medication for rare diseases and adaptive trial design.
Read the latest trends and predictions on clinical outsourcing and research due to new regulations and pressure to reduce the costs of drug development
Quanticate explores the rise, the issues, and challenges of Adaptive Clinical Trials and the ways to adapt your study, with examples of oncology study design.
Quanticate looks the use of Bayesian Study Design and Interim Analysis In Clinical Trials to improve efficiency in Drug Development.
Quanticates statistical consultancy team gives an introduction to biostatistics in clinical trials and the topics our company blog will cover.
© 2024 Quanticate